Monday, April 03, 2023 1:45:12 PM
Recent ARTL News
- Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy • GlobeNewswire Inc. • 04/23/2024 12:30:00 PM
- Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time • GlobeNewswire Inc. • 04/22/2024 12:30:00 PM
- Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge • GlobeNewswire Inc. • 03/12/2024 01:15:00 PM
- Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy • GlobeNewswire Inc. • 01/23/2024 01:30:00 PM
- Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12 • GlobeNewswire Inc. • 01/08/2024 01:30:00 PM
- Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany • GlobeNewswire Inc. • 12/05/2023 01:30:00 PM
- Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany • GlobeNewswire Inc. • 11/30/2023 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:02:44 PM
- Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/13/2023 01:00:00 PM
- Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain Cancers • GlobeNewswire Inc. • 11/09/2023 02:00:00 PM
- Artelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12 and ART12.11 in Anxiety and Depression at Neuroscience 2023 • GlobeNewswire Inc. • 11/02/2023 12:30:00 PM
- Principal Investigator of Artelo’s CAReS Trial to Participate in Medical Expert Webinar Hosted by H.C. Wainwright to Discuss Current Development Strategies for Cancer-Related Anorexia and Cachexia • GlobeNewswire Inc. • 10/04/2023 12:30:00 PM
- Artelo Biosciences to Present at the 13th Congress of the European Pain Federation on September 20th • GlobeNewswire Inc. • 09/13/2023 12:30:00 PM
- Artelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12 • GlobeNewswire Inc. • 09/07/2023 12:00:00 PM
- Artelo Biosciences to Present at the 6th Cannabinoid-Derived Drug Development Summit on September 12th • GlobeNewswire Inc. • 09/06/2023 01:00:00 PM
- Artelo Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 13th • GlobeNewswire Inc. • 09/05/2023 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 12:00:50 PM
- Artelo Biosciences Reports Second Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/10/2023 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2023 08:57:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 08:34:15 PM
- Artelo Biosciences to Present New Mechanism of Action Data on ART26.12 at the Gordon Research Conference on July 20, 2023 • GlobeNewswire Inc. • 07/19/2023 01:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/17/2023 04:15:28 AM
- Artelo Biosciences CEO to Participate in the Benzinga All Access Event on July 11 • GlobeNewswire Inc. • 07/10/2023 12:30:00 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 07/07/2023 12:23:07 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM